Send us Feedback

Amgen (AMGN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
(Latest | Earliest) View (previous 50) (next 50)

Diff selection: mark the radio boxes of the versions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with current version, (last) = difference with preceding version, M = minor edit.

(cur)(last)10:41, February 4, 201310.10.12.14 (Talk) (→Tightening FDA Regulations)
(cur)(last)17:53, December 14, 2012Wikinvest MaintenanceBot (Talk | contribs) (Reverting)
(cur)(last)16:03, August 26, 2012108.224.160.108 (Talk) (→References)
(cur)(last)08:13, June 17, 2012101.115.12.124 (Talk) (→Tightening FDA Regulations)
(cur)(last)08:12, June 17, 2012101.115.12.124 (Talk) (→Tightening FDA Regulations)
(cur)(last)15:04, April 2, 2012Anjee78 (Talk | contribs) (→Epogen ($2.52B in 2010))[stable]
(cur)(last)09:55, April 2, 2012134.173.98.104 (Talk) (→Tightening FDA Regulations)[stable]
(cur)(last)06:37, March 12, 2012216.136.115.82 (Talk) (→Nephrology)[stable]
(cur)(last)17:04, February 8, 2012Anjee78 (Talk | contribs) (Undo revision 1540397 by Special:Contributions/168.9.22.67 (User talk:168.9.22.67))[stable]
(cur)(last)10:32, February 8, 2012168.9.22.67 (Talk) (→Epogen ($2.52B in 2010))[stable]
(cur)(last)02:24, September 12, 2011167.83.101.23 (Talk)[stable]
(cur)(last)11:54, September 11, 201124.110.87.80 (Talk) (→Neupogen & Neulasta ($4.84B combined revenue in 2010))[stable]
(cur)(last)18:19, April 29, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)05:46, April 29, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)20:44, March 23, 2011Wraasch (Talk | contribs) (→National Coverage Decision)[stable]
(cur)(last)20:40, March 23, 2011Wraasch (Talk | contribs) (→Vectibix)[stable]
(cur)(last)08:00, March 23, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)08:32, February 28, 2011Kkparikh (Talk | contribs) (→National Coverage Decision)[stable]
(cur)(last)08:26, February 28, 2011Kkparikh (Talk | contribs) (→Business Segments)[stable]
(cur)(last)08:24, February 28, 2011Kkparikh (Talk | contribs) (→Business Segments)[stable]
(cur)(last)08:23, February 28, 2011Kkparikh (Talk | contribs) (→Denosumab/Prolia)[stable]
(cur)(last)08:16, February 28, 2011Kkparikh (Talk | contribs) (→Immunology)[stable]
(cur)(last)08:06, February 28, 2011Kkparikh (Talk | contribs) (→AMG 386 - Tumor-starving compound)[stable]
(cur)(last)08:03, February 28, 2011Kkparikh (Talk | contribs) (→Therapeutics)[stable]
(cur)(last)07:57, February 28, 2011Kkparikh (Talk | contribs) (→Aranesp)[stable]
(cur)(last)07:56, February 28, 2011Kkparikh (Talk | contribs) (→Neupogen & Neulasta)[stable]
(cur)(last)07:52, February 28, 2011Kkparikh (Talk | contribs) (→Sensipar)[stable]
(cur)(last)07:51, February 28, 2011Kkparikh (Talk | contribs) (→Epogen)[stable]
(cur)(last)07:50, February 28, 2011Kkparikh (Talk | contribs) (→Aranesp)[stable]
(cur)(last)07:44, February 28, 2011Kkparikh (Talk | contribs) (→Epogen)[stable]
(cur)(last)07:41, February 28, 2011Kkparikh (Talk | contribs) (→Business Segments)[stable]
(cur)(last)07:21, February 28, 2011Kkparikh (Talk | contribs) (→Recent News)[stable]
(cur)(last)22:47, February 27, 2011Kkparikh (Talk | contribs)[stable]
(cur)(last)22:15, February 21, 2011Kkparikh (Talk | contribs) (→Business Update)[stable]
(cur)(last)08:32, February 21, 2011Wraasch (Talk | contribs)[stable]
(cur)(last)23:36, February 20, 2011Kkparikh (Talk | contribs)[stable]
(cur)(last)11:39, January 27, 2011Corinnetu (Talk | contribs)[stable]
(cur)(last)20:52, January 25, 2011Kkparikh (Talk | contribs)[stable]
(cur)(last)17:25, January 25, 2011209.19.155.134 (Talk) (→Business Update)[stable]
(cur)(last)22:26, November 7, 2010Kkparikh (Talk | contribs) (→Business Update)[stable]
(cur)(last)12:16, October 14, 2010Corinnetu (Talk | contribs)[stable]
(cur)(last)12:13, October 14, 2010Corinnetu (Talk | contribs) (→Competitors)[stable]
(cur)(last)17:28, September 29, 2010Kkparikh (Talk | contribs) (→Business Segments)[stable]
(cur)(last)17:26, September 29, 2010Kkparikh (Talk | contribs) (→Trends and Forces)[stable]
(cur)(last)17:26, September 29, 2010Kkparikh (Talk | contribs) (→National Coverage Decision)[stable]
(cur)(last)17:25, September 29, 2010Kkparikh (Talk | contribs) (→National Coverage Decision)[stable]
(cur)(last)17:17, September 29, 2010Kkparikh (Talk | contribs) (→Recent News)[stable]
(cur)(last)17:17, September 29, 2010Kkparikh (Talk | contribs) (→Pricing Litigation)[stable]
(cur)(last)17:16, September 29, 2010Kkparikh (Talk | contribs) (→Corporate Overview)[stable]
(cur)(last)17:15, September 29, 2010Kkparikh (Talk | contribs)[stable]
(Latest | Earliest) View (previous 50) (next 50)
Retrieved from "http://www.wikinvest.com/stock/Amgen_(AMGN)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki